GILD vs IMG · P/E 18, rev $7.80B vs rev $1.9M
Gilead Sciences Inc (GILD) versus CIMG Inc. (IMG) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
CIMG Inc. (IMG) is a packaged foods company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported IMG revenue for 2024-09-30 was $1.9M. Net income was -$8.6M. Revenue was up 9.8% from 2023-09-30 to 2024-09-30. IMG currently screens at market cap $9.9M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. IMG currently screens at market cap $9.9M.
Not investment advice. Open the GILD and IMG stock pages for the full models.
Not investment advice.